Methionine synthase supports tumour tetrahydrofolate pools. Author Jonathan Ghergurovich, Xincheng Xu, Joshua Wang, Lifeng Yang, Rolf-Peter Ryseck, Lin Wang, Joshua Rabinowitz Publication Year 2021 Type Journal Article Abstract Mammalian cells require activated folates to generate nucleotides for growth and division. The most abundant circulating folate species is 5-methyl tetrahydrofolate (5-methyl-THF), which is used to synthesize methionine from homocysteine via the cobalamin-dependent enzyme methionine synthase (MTR). Cobalamin deficiency traps folates as 5-methyl-THF. Here, we show using isotope tracing that MTR is only a minor source of methionine in cell culture, tissues or xenografted tumours. Instead, MTR is required for cells to avoid folate trapping and assimilate 5-methyl-THF into other folate species. Under conditions of physiological extracellular folates, genetic MTR knockout in tumour cells leads to folate trapping, purine synthesis stalling, nucleotide depletion and impaired growth in cell culture and as xenografts. These defects are rescued by free folate but not one-carbon unit supplementation. Thus, MTR plays a crucial role in liberating THF for use in one-carbon metabolism. Keywords Humans, Gene Expression Regulation, Enzymologic, Cell Proliferation, Mutation, Cell Line, Tumor, Methylation, Gene Expression Regulation, Neoplastic, Metabolic Networks and Pathways, Neoplasms, Folic Acid, Methionine, Vitamin B 12 Deficiency, Tetrahydrofolates, Purines, 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase Journal Nat Metab Volume 3 Issue 11 Pages 1512-1520 Date Published 2021 Nov ISSN Number 2522-5812 DOI 10.1038/s42255-021-00465-w Alternate Journal Nat Metab PMCID PMC9284419 PMID 34799699 PubMedPubMed CentralGoogle ScholarBibTeXEndNote X3 XML